ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Gut Microbial Release of Ferulic Acid From Germinated Quinoa Alleviates Obesity-Associated Cognitive Impairment by Activating Hippocampal Mitophagy Associated with PINK1/Parkin Pathway.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Obesity is a major risk factor for cognitive impairment and related neurodegenerative disorders. Whole grains are rich in polyphenols and dietary fiber, with intake associated with improvements in obesity and cognitive deficits. Gut microbial genes encode enzymes that metabolize dietary polyphenols, thereby influencing host metabolic and neurological health; however, the specific functional microbes and enzymes involved remain largely unknown. Here, we demonstrate that germinated quinoa (GQF), a polyphenol-enriched whole-grain intervention, alleviates high-fat diet-induced cognitive impairment and restores gut microbial diversity more effectively than native quinoa (QF). These benefits correlate with enriched Roseburia abundance and enhanced carbohydrate-active enzyme (CAZyme) gene profiles, particularly genes encoding feruloyl esterase (FAE). GQF exerts neuroprotective effects via a microbiota-substrate co-dependent pattern, rather than simply relying on gut microbiota alone. Specifically, GQF selectively promotes FAE-harboring Roseburia hominis and R. intestinalis proliferation, thereby facilitating the release of bound ferulic acid (FA) from GQF. Liberated FA promotes neuronal growth and synaptic plasticity by activating PINK1/Parkin-dependent hippocampal mitophagy. These results underscore the indispensable role of specific gut microbes in unlocking the nutritional efficacy of GQF. In conclusion, dietary GQF and its microbe-releasable FA represent a natural nutritional strategy, providing a promising preventive and adjuvant approach for metabolic-related cognitive dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.